Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized, Double-Blind Study of AK1830 in Patients with Low Back Pain
jRCT2080225352Phase 2Completed
- Sponsor
- Asahi Kasei Corporation
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in lumbodynia (LBP) comparing AK1830 with Placebo (2 arms). Started Aug 2020; status: completed.
02
Drugs
AK-1830
03
Conditions
lumbodynia (LBP)
Beyond the preview
Go deeper on jRCT2080225352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225352.